Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $4,950 | 3 | 60.3% |
| Food and Beverage | $1,613 | 40 | 19.7% |
| Travel and Lodging | $945.62 | 3 | 11.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $695.00 | 1 | 8.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Philips North America LLC | $5,451 | 4 | $0 (2024) |
| Intuitive Surgical, Inc. | $1,799 | 6 | $0 (2019) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $224.08 | 4 | $0 (2022) |
| Akcea Therapeutics, Inc. | $119.88 | 1 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $105.79 | 4 | $0 (2018) |
| Kestra Medical Technology Services, Inc. | $92.00 | 1 | $0 (2023) |
| Allergan Inc. | $63.63 | 4 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $62.85 | 5 | $0 (2017) |
| LifeWatch Services Inc | $46.38 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $40.26 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,451 | 4 | Philips North America LLC ($5,451) |
| 2023 | $92.00 | 1 | Kestra Medical Technology Services, Inc. ($92.00) |
| 2022 | $137.15 | 3 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($119.13) |
| 2019 | $1,929 | 8 | Intuitive Surgical, Inc. ($1,778) |
| 2018 | $163.56 | 3 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($85.67) |
| 2017 | $431.68 | 28 | Allergan Inc. ($63.63) |
All Payment Transactions
47 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Philips North America LLC | (2858) General Consulting (Device) | Consulting Fee | Cash or cash equivalent | $1,650.00 | General |
| Category: Medical Device | ||||||
| 10/10/2024 | Philips North America LLC | (2858) General Consulting (Device) | Travel and Lodging | In-kind items and services | $500.95 | General |
| Category: Medical Device | ||||||
| 09/23/2024 | Philips North America LLC | (2858) General Consulting (Device) | Consulting Fee | Cash or cash equivalent | $1,100.00 | General |
| Category: Medical Device | ||||||
| 08/21/2024 | Philips North America LLC | (2858) General Consulting (Device) | Consulting Fee | Cash or cash equivalent | $2,200.00 | General |
| Category: Medical Device | ||||||
| 07/06/2023 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $92.00 | General |
| Category: Cardiology | ||||||
| 08/29/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $99.71 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/29/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.42 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/22/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Oncology | ||||||
| 10/10/2019 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $695.00 | General |
| Category: SURGERY | ||||||
| 10/10/2019 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $471.17 | General |
| Category: SURGERY | ||||||
| 08/26/2019 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $417.67 | General |
| Category: SURGERY | ||||||
| 08/26/2019 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $27.00 | General |
| Category: SURGERY | ||||||
| 04/30/2019 | Akcea Therapeutics, Inc. | TEGSEDI (Drug) | Food and Beverage | In-kind items and services | $119.88 | General |
| Category: NEUROLOGY | ||||||
| 04/30/2019 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: WOMENS HEALTH | ||||||
| 01/30/2019 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $167.30 | General |
| Category: SURGERY | ||||||
| 01/22/2019 | CARDIVA MEDICAL, INC. | Vascular Closure Device (Device) | Food and Beverage | Cash or cash equivalent | $18.07 | General |
| Category: Vascular Closure | ||||||
| 12/28/2018 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: SURGERY | ||||||
| 11/16/2018 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $85.67 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/17/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $57.10 | General |
| Category: DIABETES | ||||||
| 12/07/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.84 | General |
| Category: Cardiovascular | ||||||
| 11/15/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/08/2017 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/03/2017 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/14/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 08/28/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,700 | 1,923 | $490,891 | $85,473 |
| 2022 | 15 | 1,307 | 1,494 | $382,055 | $70,275 |
| 2021 | 15 | 1,505 | 1,743 | $393,688 | $77,889 |
| 2020 | 16 | 904 | 1,012 | $276,075 | $55,743 |
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 227 | 230 | $171,968 | $25,071 | 14.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 157 | 187 | $82,918 | $17,669 | 21.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 197 | 235 | $74,435 | $15,476 | 20.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 136 | 138 | $47,044 | $7,191 | 15.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 392 | 433 | $30,797 | $4,320 | 14.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $19,644 | $4,212 | 21.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 51 | 53 | $16,023 | $3,175 | 19.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 255 | 346 | $14,098 | $2,150 | 15.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 20 | $4,720 | $1,259 | 26.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $6,057 | $1,243 | 20.5% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 44 | 46 | $4,888 | $765.32 | 15.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 13 | 13 | $4,626 | $690.71 | 14.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 15 | $2,930 | $677.55 | 23.1% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 55 | 57 | $4,086 | $627.24 | 15.4% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 19 | 19 | $2,343 | $373.16 | 15.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 68 | 69 | $2,760 | $341.85 | 12.4% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 12 | 12 | $1,554 | $230.70 | 14.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 145 | 186 | $77,985 | $16,571 | 21.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 126 | 126 | $104,415 | $15,851 | 15.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 167 | 201 | $59,199 | $12,547 | 21.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 131 | 133 | $43,128 | $7,171 | 16.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 34 | 34 | $18,522 | $3,774 | 20.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 253 | 275 | $18,758 | $2,567 | 13.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 39 | 42 | $11,774 | $2,390 | 20.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 245 | 318 | $12,102 | $2,108 | 17.4% |
About Dr. Michael Balk, MD
Dr. Michael Balk, MD is a Cardiovascular Disease healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1205820024.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Balk, MD has received a total of $8,204 in payments from pharmaceutical and medical device companies, with $5,451 received in 2024. These payments were reported across 47 transactions from 20 companies. The most common payment nature is "Consulting Fee" ($4,950).
As a Medicare-enrolled provider, Balk has provided services to 5,416 Medicare beneficiaries, totaling 6,172 services with total Medicare billing of $289,379. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Atlanta, GA
- Active Since 09/08/2005
- Last Updated 05/17/2018
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1205820024
Products in Payments
- (2858) General Consulting (Device) $5,451
- Da Vinci Surgical System (Device) $1,799
- LifeVest (Device) $224.08
- TEGSEDI (Drug) $119.88
- Assure WCD (Device) $92.00
- BYSTOLIC (Drug) $63.63
- ENTRESTO (Drug) $62.85
- JARDIANCE (Drug) $57.10
- PRADAXA (Drug) $48.69
- Cardiac Monitoring Suite (Device) $46.38
- BRILINTA (Drug) $40.26
- Corlanor (Drug) $35.05
- PRALUENT ALIROCUMAB INJECTION (Biological) $27.23
- ELIQUIS (Drug) $24.78
- XARELTO (Drug) $22.04
- Vascular Closure Device (Device) $18.07
- Nubeqa (Drug) $18.02
- PRALUENT (Drug) $13.93
- CHANTIX (Drug) $13.10
- NEXPLANON (Drug) $12.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Atlanta
David Kandzari, Md, MD
Cardiovascular Disease — Payments: $1.3M
William Nicholson, Md, MD
Cardiovascular Disease — Payments: $1.2M
Dr. Joseph Miller, Md, MD
Cardiovascular Disease — Payments: $767,251
Adam Greenbaum, M.d, M.D
Cardiovascular Disease — Payments: $377,582
Randolph Martin, Md, MD
Cardiovascular Disease — Payments: $358,457
Dr. Thomas Deering, Md, MD
Cardiovascular Disease — Payments: $237,098